References
- Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17–20.10.1016/S0025-6196(12)60336-X
- Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148–52.10.1056/NEJM198805053181802
- Nkomo VT, Theuma P, Maniu CV, Chandrasekaran K, Miller FA, Schaff HV, Petty GW, Miller TD.et al. Patent foramen ovale transcatheter closure device thrombosis. Mayo Clin Proc. 2001;76:1057–61.10.4065/76.10.1057
- Khatchatourov G, Kalangos A, Anwar A, Urban P, De Moerloose P, Friedli B, Faidutti B. Massive thromboembolism due to transcatheter ASD closure with ASDOS device. J Invasive Cardiol. 1999;11:743–5.
- Sievert H, Babic UU, Hausdorf G, Schneider M, Höpp HW, Pfeiffer D, Pfisterer M, Friedli B, Urban P. Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial). Am J Cardiol. 1998;82:1405–13.10.1016/S0002-9149(98)00650-X
- Sievert H, Horvath K, Zadan E, Krumsdorf U, Fach A, Merle H, Scherer D, Schrader R, Spies H, Nowak B, Lissmann-Jensen H. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interv Cardiol. 2001;14:261–6.10.1111/joic.2001.14.issue-2
- La Rosée K, Deutsch HJ, Schnabel P, Schneider CA, Burkhard-Meier C, Höpp HW. Thrombus formation after transcatheter closure of atrial septal defect. Am J Cardiol. 1999;84:356–9.10.1016/S0002-9149(99)00296-9
- Franke A, Kuhl HP, Muhler EG, Nussbaum J, Visser L, Lepper W, Hanrath P. Frequency of occluder-related atrial thrombi despite different prophylactic therapy after transcatheter closure of a patent foramen ovale (abstr). Eur Heart J. 2000;21:25–25.
- Krumsdorf U, Keppeler P, Horvath K, Zadan E, Schrader R, Sievert H. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices. J Interv Cardiol. 2001;14:49–55.10.1111/joic.2001.14.issue-1
- Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002;106(9):1121–26.10.1161/01.CIR.0000027819.19722.EE
- Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43(2):302–9.10.1016/j.jacc.2003.10.030
- Anzai H, Child J, Natterson B, Krivokapich J, Fishbein MC, Chan VK, Tobis JM. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol. 2004;93(4):426–31.10.1016/j.amjcard.2003.10.036